Works by Myung Joo Kang


Results: 50
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers.

    Published in:
    2016
    By:
    • Park, Ji;
    • Kang, Myung;
    • Ahn, Jin-Hee;
    • Kim, Jeong;
    • Jung, Kyung;
    • Gong, Gyungyub;
    • Lee, Hee;
    • Son, Byung-Ho;
    • Ahn, Sei-Hyun;
    • Kim, Hak-Hee;
    • Shin, Hee;
    • Moon, Dae-Hyuk;
    • Kim, Sung-Bae;
    • Park, Ji Hyun;
    • Kang, Myung Joo;
    • Kim, Jeong Eun;
    • Jung, Kyung Hae;
    • Lee, Hee Jin;
    • Shin, Hee Jung
    Publication type:
    journal article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50